FindTrial
Sign In

How the Yokohama System Helps in Diagnosing Breast Lesions through Cytology

Diagnostic utility of the Yokohama system in reporting cytology of breast lesions - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/095079
Enrollment
131
Registered
2025-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D24- Benign neoplasm of breast Health Condition 2: C50- Malignant neoplasm of breast

Interventions

Control Intervention1: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education & Research (DMIHER)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All the female patients presenting with palpable breast lumps.

Exclusion criteria

Exclusion criteria: 1. All the patients already diagnosed as breast carcinoma. 2. All the operated cases of breast carcinoma. 3. All patients with breast carcinoma which is arising as a result of recurrence. 4. All the patients not willing for participation in the study and males.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of Yokohama system in differentiating benign and malignant breast lesions.Timepoint: 2 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactGaurav Soni

Datta Meghe Institute of Higher Education & Research (DMIHER)

dranilagrawal.456@gmail.com9850309278

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026